Head to Head Survey: Akso Health Group (NASDAQ:AHG) & Coupang (NYSE:CPNG)

Coupang (NYSE:CPNGGet Free Report) and Akso Health Group (NASDAQ:AHGGet Free Report) are both retail/wholesale companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, risk, earnings, institutional ownership, analyst recommendations and valuation.

Profitability

This table compares Coupang and Akso Health Group’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Coupang 1.13% 7.47% 1.98%
Akso Health Group N/A N/A N/A

Analyst Ratings

This is a summary of current ratings and recommmendations for Coupang and Akso Health Group, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Coupang 0 2 5 1 2.88
Akso Health Group 0 0 0 0 0.00

Coupang presently has a consensus price target of $31.14, suggesting a potential upside of 7.78%. Given Coupang’s stronger consensus rating and higher possible upside, equities analysts plainly believe Coupang is more favorable than Akso Health Group.

Institutional and Insider Ownership

83.7% of Coupang shares are owned by institutional investors. Comparatively, 1.2% of Akso Health Group shares are owned by institutional investors. 12.8% of Coupang shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Risk & Volatility

Coupang has a beta of 1.15, meaning that its share price is 15% more volatile than the S&P 500. Comparatively, Akso Health Group has a beta of -0.55, meaning that its share price is 155% less volatile than the S&P 500.

Valuation and Earnings

This table compares Coupang and Akso Health Group”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Coupang $30.27 billion 1.74 $154.00 million $0.20 144.48
Akso Health Group $14.78 million 17.06 -$134.98 million N/A N/A

Coupang has higher revenue and earnings than Akso Health Group.

Summary

Coupang beats Akso Health Group on 12 of the 13 factors compared between the two stocks.

About Coupang

(Get Free Report)

Coupang, Inc., together with its subsidiaries owns and operates retail business through its mobile applications and Internet websites primarily in South Korea. The company operates through Product Commerce and Developing Offerings segments. It sells various products and services in the categories of home goods and décor products, apparel, beauty products, fresh food and groceries, sporting goods, electronics, and everyday consumables, as well as travel, and restaurant order and delivery services. In addition, the company offers Rocket Fresh, which offers fresh groceries; Coupang Eats, a restaurant ordering and delivery services; and Coupang Play, an online content streaming services, as well as advertising products. It also performs operations and support services in the United States, South Korea, Taiwan, Singapore, China, Japan, and India. Coupang, Inc. was incorporated in 2010 and is headquartered in Seattle, Washington.

About Akso Health Group

(Get Free Report)

Akso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. It also offers consultancy and information technology support services; provides health treatment services; sells medical devices; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Receive News & Ratings for Coupang Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coupang and related companies with MarketBeat.com's FREE daily email newsletter.